The Diabetes Cascade of Care Through the 14 Years in Iran: Findings of Nationwide Steps Surveys 2007–2021 Publisher



Ameli A¹ ; Sheikhy A¹ ; Tabatabaeimalazy O^{1, 2} ; Ahmadi N¹ ; Ebrahimpur M³ ; Fallahzadeh A¹ ; Rashidi MM¹ ; Golestani A¹ ; Yoosefi M^{1, 4} ; Farzi Y¹ ; Dilmaghanimarand A¹ ; Rezaei N^{1, 5} ; Larijani B² ; Farzadfar F^{1, 2} Show Affiliations
Source: Journal of Diabetes and Metabolic Disorders Published:2023

Abstract

Background: Diabetes as the leading cause of mortality and morbidity, have been increased by about 35% from 2011 to 2015 worldwide. The objective of this study was to assess the trend and pattern of diabetes and prediabetes prevalence in Iran and also evaluate the diagnosis and status of diabetes management. Methods: The results of this study are extracted from the National Stepwise approach to non-communicable disease risk factor surveillance (STEPS), conducted in 2007, 2011, 2016, and 2021 in Iran. We evaluated all obtained data by questionnaires (demographic, epidemiologic, risk-related behavioral data), physical measurements, and laboratory measures. Results: The prevalence of diabetes almost doubled from 2007 to 2021 among adults 25 years old and above. Diabetes prevalence increased from 10.85% (95% CI:10.30–11.40) in 2016 to 14.15% (13.42–14.87) in 2021. Prediabetes prevalence increased from 18.11% (17.46- 18,76) in 2016 to 24.81% (23.88–25.74) in 2021. Diabetes diagnosis stayed constant hence; diabetes coverage improved from 56.87% (54.21–59.52) to 65.04% (62.40- 67.69). Despite an enhancement in diabetes diagnosis and coverage, diabetes effective care did not improve significantly during 2016 and 2021, with a number of 35.98% (32.60- 39.36) in 2016 and 31.35% (28.20- 34.51) in 2021. Conclusion: The prevalence of diabetes and prediabetes in Iran is almost doubled during the past 14 years. Although, several health policies had been developed to improve the screening and quality of diabetes care; there are still significant gaps in the effective control of diabetes. Accordingly, the current care plan should be reviewed. © 2023, The Author(s), under exclusive licence to Tehran University of Medical Sciences.